GlassScriptPhysician profile
Karen T Brown
NPI 1558349225
$12,515.36
in general payments reported to CMS, 2019-2025
7 companies · $223 in 2025
The $223 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $216 · 2021: $628 · 2022: $10K · 2023: $1,311 · 2024: $88.78 · 2025: $223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,223 · Food and Beverage: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,223.02 |
| Food and Beverage | $399.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Instylla, INC. | $11,000.13 | 2022-2024 | Instylla Delivery Kit, Instylla Microcatheter |
| Astrazeneca Pharmaceuticals LP | $923.64 | 2021-2022 | |
| Boston Scientific Corporation | $216.25 | 2019 | |
| Galvanize Therapeutics, INC | $139.78 | 2025 | Aliya System |
| Incyte Corporation | $109.99 | 2022 | |
| Cook Medical LLC | $83.00 | 2025 | Cook |
| Terumo Medical Corporation | $42.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.